Please sign in to follow a disease.

Xeroderma pigmentosum group B

MONDO:0012531

Any xeroderma pigmentosum in which the cause of the disease is a mutation in the ERCC3 gene.

Also known as: ERCC3 xeroderma pigmentosum, XP, Group B, XP-B, XPB, XPBC, xeroderma pigmentosum caused by mutation in ERCC3, xeroderma pigmentosum group B, xeroderma pigmentosum group type B

3 clinical trials for this condition and its sub-types, 0 tagged with Xeroderma pigmentosum group B itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ Xeroderma pigmentosum (6) ↑ Xeroderma pigmentosum-Cockayne syndrome complex (2)

Including sub-types (3) Tagged with Xeroderma pigmentosum group B (0)

Trials to join now! 1 Not yet finished but already full! 1 Completed 1

New drug combo targets Hard-to-Treat cancers in early trial

Disease control Recruiting now

This study tests a new drug called AZD4956, alone or with other cancer drugs, in people with advanced or spreading solid tumors that have a specific DNA repair defect (HRR deficiency). The main goals are to check safety, find the best dose, and see if the drug can shrink tumors. …

Phase 1/2 • Sponsor: AstraZeneca • Aim: Disease control

Last updated Sep 10, 2026 00:00 UTC

Xeroderma pigmentosum group B

Where it sits in the disease tree

New drug combo targets Hard-to-Treat cancers in early trial